Atlas Trials

Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer

Clinical trial NCT05896839 · RECRUITING

Trial details

NCT number
NCT05896839
Sponsor
National Cancer Institute (NCI)
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8Metastatic Basal Cell CarcinomaMetastatic Carcinoma in the SkinMetastatic MelanomaMetastatic Merkel Cell CarcinomaMetastatic Skin Squamous Cell CarcinomaUnresectable Basal Cell CarcinomaUnresectable MelanomaUnresectable Merkel Cell Carcinoma
Start date
2024-07-24
Primary completion
2027-01-31
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.